Biorestorative Therapies Stock Operating Margin

BRTX Stock

USD 1.47 0.02 1.34%

BioRestorative Therapies fundamentals help investors to digest information that contributes to BioRestorative Therapies' financial success or failures. It also enables traders to predict the movement of BioRestorative Stock. The fundamental analysis module provides a way to measure BioRestorative Therapies' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BioRestorative Therapies stock.

		Last Reported	Projected for Next Year
	Operating Profit Margin	(104.39)	(109.61)

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

BioRestorative Therapies Company Operating Margin Analysis

BioRestorative Therapies' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

Operating Margin

Operating Income

Revenue

100

More About Operating Margin | All Equity Analysis

Current BioRestorative Therapies Operating Margin

(9.79) %

Most of BioRestorative Therapies' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BioRestorative Therapies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

BioRestorative Operating Margin Driver Correlations

Understanding the fundamental principles of building solid financial models for BioRestorative Therapies is extremely important. It helps to project a fair market value of BioRestorative Stock properly, considering its historical fundamentals such as Operating Margin. Since BioRestorative Therapies' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of BioRestorative Therapies' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of BioRestorative Therapies' interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Accounts Payable	Total Liab	Intangible Assets	Common Stock	Property Plant Equipment	Net Debt	Retained Earnings	Long Term Debt	Total Current Assets	Treasury Stock	Short Term Debt	Current Deferred Revenue	Net Tangible Assets	Short Long Term Debt	Net Receivables	Net Invested Capital	Net Working Capital	Capital Stock	Long Term Debt Total	Capital Surpluse
Total Assets		0.96	-0.64	-0.73	0.05	-0.29	0.24	-0.84	-0.8	-0.39	0.97	0.38	-0.6	-0.47	0.93	-0.66	-0.53	0.95	0.95	-0.03	-0.39	-0.39
Total Stockholder Equity	0.96		-0.72	-0.88	0.16	-0.13	0.12	-0.82	-0.68	-0.4	0.91	0.38	-0.74	-0.58	0.91	-0.66	-0.4	0.91	0.92	-0.01	-0.38	-0.38
Accounts Payable	-0.64	-0.72		0.73	-0.23	-0.35	0.35	0.44	0.39	-0.1	-0.58	-0.34	0.53	0.6	-0.6	0.26	0.09	-0.61	-0.65	-0.28	0.34	0.34
Total Liab	-0.73	-0.88	0.73		-0.33	-0.17	0.12	0.64	0.36	0.36	-0.64	-0.3	0.85	0.67	-0.71	0.56	0.1	-0.68	-0.72	-0.03	0.3	0.3
Intangible Assets	0.05	0.16	-0.23	-0.33		0.24	-0.24	0.02	0.34	-0.23	-0.2	-0.1	-0.2	-0.21	-0.18	0.27	0.34	-0.18	-0.18	-0.1	0.08	0.08
Common Stock	-0.29	-0.13	-0.35	-0.17	0.24		-0.64	0.18	0.52	0.6	-0.33	-0.22	-0.18	-0.23	-0.32	0.42	0.53	-0.28	-0.27	0.14	0.22	0.22
Property Plant Equipment	0.24	0.12	0.35	0.12	-0.24	-0.64		-0.11	-0.42	-0.32	0.27	0.28	0.11	0.14	0.27	-0.28	-0.33	0.22	0.16	-0.37	-0.16	-0.16
Net Debt	-0.84	-0.82	0.44	0.64	0.02	0.18	-0.11		0.53	0.33	-0.83	-0.11	0.56	0.34	-0.74	0.59	0.43	-0.84	-0.81	0.01	0.1	0.1
Retained Earnings	-0.8	-0.68	0.39	0.36	0.34	0.52	-0.42	0.53		0.2	-0.86	-0.56	0.41	0.07	-0.86	0.76	0.8	-0.82	-0.84	-0.15	0.53	0.53
Long Term Debt	-0.39	-0.4	-0.1	0.36	-0.23	0.6	-0.32	0.33	0.2		-0.32	-0.23	0.21	0.4	-0.39	0.35	0.1	-0.29	-0.3	0.48	0.23	0.23
Total Current Assets	0.97	0.91	-0.58	-0.64	-0.2	-0.33	0.27	-0.83	-0.86	-0.32		0.4	-0.55	-0.42	0.96	-0.71	-0.59	0.98	0.98	-0.01	-0.4	-0.4
Treasury Stock	0.38	0.38	-0.34	-0.3	-0.1	-0.22	0.28	-0.11	-0.56	-0.23	0.4		-0.35	-0.31	0.6	-0.43	-0.3	0.33	0.4	-0.07	-0.8	-0.8
Short Term Debt	-0.6	-0.74	0.53	0.85	-0.2	-0.18	0.11	0.56	0.41	0.21	-0.55	-0.35		0.32	-0.66	0.74	0.28	-0.59	-0.65	-0.26	0.34	0.34
Current Deferred Revenue	-0.47	-0.58	0.6	0.67	-0.21	-0.23	0.14	0.34	0.07	0.4	-0.42	-0.31	0.32		-0.48	0.01	-0.31	-0.41	-0.42	0.46	0.31	0.31
Net Tangible Assets	0.93	0.91	-0.6	-0.71	-0.18	-0.32	0.27	-0.74	-0.86	-0.39	0.96	0.6	-0.66	-0.48		-0.79	-0.56	0.93	0.96	0.01	-0.6	-0.6
Short Long Term Debt	-0.66	-0.66	0.26	0.56	0.27	0.42	-0.28	0.59	0.76	0.35	-0.71	-0.43	0.74	0.01	-0.79		0.66	-0.72	-0.78	-0.34	0.42	0.42
Net Receivables	-0.53	-0.4	0.09	0.1	0.34	0.53	-0.33	0.43	0.8	0.1	-0.59	-0.3	0.28	-0.31	-0.56	0.66		-0.57	-0.58	-0.25	0.28	0.28
Net Invested Capital	0.95	0.91	-0.61	-0.68	-0.18	-0.28	0.22	-0.84	-0.82	-0.29	0.98	0.33	-0.59	-0.41	0.93	-0.72	-0.57		0.98	0.08	-0.27	-0.27
Net Working Capital	0.95	0.92	-0.65	-0.72	-0.18	-0.27	0.16	-0.81	-0.84	-0.3	0.98	0.4	-0.65	-0.42	0.96	-0.78	-0.58	0.98		0.14	-0.4	-0.4
Capital Stock	-0.03	-0.01	-0.28	-0.03	-0.1	0.14	-0.37	0.01	-0.15	0.48	-0.01	-0.07	-0.26	0.46	0.01	-0.34	-0.25	0.08	0.14		0.07	0.07
Long Term Debt Total	-0.39	-0.38	0.34	0.3	0.08	0.22	-0.16	0.1	0.53	0.23	-0.4	-0.8	0.34	0.31	-0.6	0.42	0.28	-0.27	-0.4	0.07		1.0
Capital Surpluse	-0.39	-0.38	0.34	0.3	0.08	0.22	-0.16	0.1	0.53	0.23	-0.4	-0.8	0.34	0.31	-0.6	0.42	0.28	-0.27	-0.4	0.07	1.0

Click cells to compare fundamentals

A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.

Competition

Predict BioRestorative Therapies

Operating Profit Margin Over Time

BioRestorative Pretax Profit Margin

Pretax Profit Margin

(75.02)

At this time, BioRestorative Therapies' Pretax Profit Margin is fairly stable compared to the past year.

Based on the recorded statements, BioRestorative Therapies has an Operating Margin of -9.7902%. This is 72.09% lower than that of the Biotechnology sector and 91.26% lower than that of the Health Care industry. The operating margin for all United States stocks is 77.68% higher than that of the company.

BioRestorative Operating Margin Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BioRestorative Therapies' direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of BioRestorative Therapies could also be used in its relative valuation, which is a method of valuing BioRestorative Therapies by comparing valuation metrics of similar companies.

BioRestorative Therapies is currently under evaluation in operating margin category among its peers.

BioRestorative Fundamentals

	Return On Equity	-0.17
	Return On Asset	-0.53
	Operating Margin	(9.79) %
	Current Valuation	(2.72 M)
	Shares Outstanding	6.92 M
	Shares Owned By Insiders	26.61 %
	Shares Owned By Institutions	13.74 %
	Number Of Shares Shorted	74.44 K
	Price To Earning	(1.79) X
	Price To Book	1.03 X
	Price To Sales	26.98 X
	Revenue	145.8 K
	Gross Profit	119.8 K
	EBITDA	(15.06 M)
	Net Income	(10.42 M)
	Cash And Equivalents	17.93 M
	Cash Per Share	4.92 X
	Total Debt	162.32 K
	Debt To Equity	0.02 %
	Current Ratio	29.47 X
	Book Value Per Share	1.44 X
	Cash Flow From Operations	(6.43 M)
	Short Ratio	2.48 X
	Earnings Per Share	(2.38) X
	Target Price	13.0
	Number Of Employees	11
	Beta	62.82
	Market Capitalization	10.17 M
	Total Asset	12.61 M
	Retained Earnings	(146.7 M)
	Working Capital	8.78 M
	Current Asset	289.28 K
	Current Liabilities	5.61 M
	Net Asset	12.61 M

About BioRestorative Therapies Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze BioRestorative Therapies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BioRestorative Therapies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BioRestorative Therapies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Additional Tools for BioRestorative Stock Analysis

When running BioRestorative Therapies' price analysis, check to measure BioRestorative Therapies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioRestorative Therapies is operating at the current time. Most of BioRestorative Therapies' value examination focuses on studying past and present price action to predict the probability of BioRestorative Therapies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioRestorative Therapies' price. Additionally, you may evaluate how the addition of BioRestorative Therapies to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC